Chris Chapman is delighted at GlucoRx’s achievement at the Surrey Super Growth Awards this year, ranking 6th out of 50,000 companies.
Lloyds Bank, asb law, and RSM compiled a shortlist of finalists based on profitable turnover growth over a four-year accounting period, using information filed at Companies House.
It was the first time GlucoRx attended the Super Growth Awards, being one of the top 50 companies invited to the Awards’ Breakfast.
The Surrey Super Growth Awards commented on GlucoRx in their top 50 published list. “It was great to be recognised for all the good work our Company has been doing, not only locally but across the whole of the UK”, said Chris Chapman.
GlucoRx would like to congratulate the 2019 winners ‘Stenball Group Limited’ with their winning growth of 267%, and look forward to qualifying for next year’s 2020 awards.
Diabetes Awareness Week is here! From 10th – 16th June, you’ll have a unique opportunity to really make some noise and talk about diabetes with your family, friends and work colleagues. This is a time to share your “diabetes” experiences; are you diagnosed with diabetes? Do you know somebody that is? Support others effectively manage their condition, as well as make a difference to your own health by checking out some helpful resources and learning more about the various types of diabetes management solutions that are available, like blood glucose monitoring systems, insulin pen needles, glucose gels or footcare foam-creams.
Organised by Diabetes UK, one of the country’s leading diabetes charities, Diabetes Awareness Week isn’t just educational… it’s fun, too! This year, the chosen theme is “See Diabetes Differently”. Each year, we see a whole host of community events, sponsored walks/races and adrenaline-pumping challenges, all designed to help people to better cope with their condition as well as generate the essential financial resources needed to help the NHS keep researching, keep testing and keep on top of the latest advancements in essential diabetes management.
While diabetes is a very common condition — it’s estimated that more than 5 million people in the UK will be diagnosed with the condition by 2025 — the impact that the disease can have on day to day life is still not fully understood by many. If we continue to turn a ‘blind eye’ and overlook the seriousness of diabetes, it’s expected that the disease will trigger a massive care crisis in the future, especially as untreated diabetes or diabetes that is managed poorly can result in life-threatening complications. E.g. Nerve damage (neuropathy), Kidney damage (nephropathy), Eye damage (retinopathy) and Foot damage.
Perhaps the best thing that we can all do right now to prevent this from happening is to raise awareness of the disease and support those living with the condition. At GlucoRx, we’re proud to be supporting Diabetes Awareness Week 2019 with several events around the country. Members of our team will be spending time talking to the general public at community pharmacies, at a shopping centre and at one of the Silver Star Mobile Diabetes Unit.
We’d love it if you would join in offering support to this great cause and get involved in Diabetes Awareness Week 2019. Whether it’s sharing your experiences of living with the condition or participating in some of the amazing diabetes fundraising events that are being organised all around the country.
Now is the time to act. Diabetes is a manageable condition… together, we can keep it that way.
If you have type 1 diabetes or are an insulin-dependent type 2 patient, you’ll know how tricky it can be to get your daily injections right. From injection site selection and rotation to avoiding accidentally injecting into a muscle, there’s a lot to remember – and then of course, there’s the general ouch factor.
Getting your insulin injections right
Here at GlucoRx, we’re proud to support the Injection Technique Matters guidelines, because we know that getting injection technique right makes a big difference to overall blood sugar control.
To that end, we’re proud to promote our extensive range of insulin pen needles:
- A complete size range of FinePoint and CarePoint pen needles
- Universal fit on all insulin delivery pens
- FinePoint needles use quintapoint (5 bevel needle tip) technology (except 10mm + 12mm sizes) for a higher level of comfortable injection.
Safe use of insulin pen needles
Our universal fit FinePoint and CarePoint pen needles are incredibly easy to use. First of all, check with your healthcare practitioner to be sure you’re using the most suitable pen needle length.
Once you have the correct pen needle size, follow these simple steps:
1. Wash and dry your hands.
2. Remove your insulin pen cap. For cloudy insulin, roll between the palms of your hands 10 times and gently invert the pen 10 times.
3. Select a new FinePoint or CarePoint needle and attach it to the pen; remove the protective cap.
4. Test that the pen is working by selecting 2 units. Hold the pen upright and press the button to release the dose; watch to see that insulin appears at the needlepoint. If it does not, repeat the process until it does.
5. Dial the required dose on the pen.
6. Select an injection site. The most commonly used sites are the abdomen, outer thighs, upper arms or buttocks, but check with your healthcare practitioner who can advise on the best sites for you to use. Remember to rotate your injection sites.
7. Pinch your skin into a fold and fully insert the needle at 90 degrees to your skin.
8. Press the button to release the dose, holding the pen still.
9. Don’t forget to count to 10 before removing the needle, to ensure the full dose is delivered!
10. Remove the pen and take off the needle, safely disposing of it in a sharps bin.
Can I reuse insulin pen needles?
No, you should never reuse insulin pen needles. If you do, you risk the needle bending or breaking – and besides, a blunt needle makes for a more painful injection.
Why do my insulin injections hurt, bruise or bleed?
Bruising or bleeding at the injection site, although unpleasant, is not dangerous. Remember to rotate your injection sites and if you experience pain, bruising or bleeding often, review your injection technique with your healthcare practitioner.
What is lipohypertrophy?
Lipohypertrophy is a thickened area of fatty tissue which can develop at an injection site. It is important not to continue to inject into a “lipo” as the insulin absorption will be erratic, potentially leading to hypos and other complications. Ask your healthcare provider to teach you how to check for any developing “lipo” patches; these can usually be avoided through good injection technique.
If you’ve been injecting for a while, you probably don’t give much thought to your injection technique – but a combination of our Insulin pen needle offering and proper technique will help to minimise complications and maximise your wellbeing. Injection technique really does matter!
When you experience hypoglycaemia, it’s important to act fast to restore your blood glucose to a safe level before your condition worsens and becomes dangerous. GlucoRx Torq Gel is a specialist fast-acting carbohydrate gel which was developed based on scientific research from peer-reviewed findings and has been specifically designed to raise blood sugar quickly and safely.
What is hypoglycaemia?
Hypoglycaemia occurs when blood sugar drops to a very low level; it’s often referred to as having a “hypo”. During hypoglycaemia, you may experience shakiness, weakness, confusion, sleepiness, shivering, sweating and hunger. Left untreated, a diabetic coma can be the result.
What’s in GlucoRx Torq Gel?
GlucoRx Torq Gel contains a blend of two sugars, maltodextrin and fructose in a 2:1 ratio, together with five key electrolytes: potassium, sodium, chloride, calcium and magnesium. Each pack contains 3 x 23.5g sachets, enough to treat three hypos.
How does it work?
All carbohydrate gels work by delivering carbohydrates into the bloodstream via two intestinal transporters, one for glucose and one for fructose. However, these transporters can only work up to certain maximum rates. Glucose can only be absorbed at a maximum rate of 60g per hour, or 1g per minute. Fructose can be absorbed at a maximum rate of 30g per hour, or 0.5g per minute. By combining maltodextrin (a glucose derivative) and fructose, GlucoRx Torq Gel allows optimal carbohydrate delivery for quick relief of symptoms. Together, these two sugars can be absorbed at 90g per hour or 1.5g per minute – that’s over 40% better than a single glucose source, meaning that your blood sugar levels will rise faster. It is these two different transporters that allow the fast absorption of GlucoRx Torq Gel.
Super-fast carbohydrate delivery when you need it most
Research shows that swilling a carbohydrate gel around your mouth triggers an important physiological response: this action sends signals to your brain, telling it to expect a sugar delivery, and thus starting to ease symptoms even faster – GlucoRx Torq Gel starts to work before you’ve even swallowed it.
Convenience, discretion and a great taste too
The small tubes are easy to carry with you in a purse, wallet or pocket, and very easy to open and use. Simply tear the top off the tube, squeeze the contents into your mouth and swill for five seconds before swallowing. Discreet and convenient, GlucoRx Torq Gel also tastes great too – using natural flavourings, the gel is available in black cherry yoghurt or raspberry ripple flavour. It contains no artificial colours or sweeteners. The silky-smooth gel is easy to swallow – a no mess, no fuss, fast and simple solution for a hypo.
Using GlucoRx Torq Gel safely
GlucoRx Torq Gel is not suitable for children under 2 years old. It must not be given to anyone who is unconscious, due to risk of choking. If someone with diabetes falls unconscious, call 999 immediately. GlucoRx Torq Gel is designed to treat occasional hypos, but it is not a substitute for good diabetes control. If you are experiencing hypoglycaemia frequently, having trouble controlling your blood sugar or are worried about your diabetes for any other reason, consult your GP as soon as possible.
A blood glucose meter designed to increase the accuracy of readings by measuring haematocrit has outperformed three other devices (Accu-Chek Aviva, Caresens Dual and GlucoMen Areo 2K), according to a study published by Swansea University in January 2019.
Haematocrit, the volume percentage of red blood cells in blood, is known to influence glucose values obtained by blood glucose meters. Most other meters estimate haematocrit levels, and this can lead to an overestimate or underestimated variation.
It is well known that certain population groups (young, pregnant, patients undergoing specific treatments) have varying haematocrit levels; this can
The GlucoRx HCT meter, specifically designed with insulin users in mind, facilitates a wider health check by measuring haematocrit and blood glucose levels as well as ketones, providing a more reliable result. It does this through Haematocrit Correction Technology (HCT) and a study published in the Journal of Diabetes Science and Technology by Swansea University put this technology to the test by comparing the accuracy of the meter with three others.
This study compared capillary blood samples from 100 people and compared to the plasma values obtained by reference laboratory analyser.
The researchers concluded that the performance of GlucoRx HCT meter “had the best performance due to the haematocrit correction technology employed within this meter.”
To access the study titled ‘Comparative Accuracy Evaluation of a Blood Glucose Meter With Novel Haematocrit Correction Technology, With Three Currently Used Commercially Available Blood Glucose Monitoring Systems’ click here.
GlucoRx is very pleased to sponsor and unconditionally support this first edition of the “‘Injection Technique Matters – Best Practice in Diabetes Care”. Achieving the best injection technique possible enhances the lives of the many people living with diabetes having to medicate with injectables, helping them to obtain the best possible (and individualised) outcomes and to minimise the risks involved. It is vitally important for them to be taught correctly from the outset and to have access to the most relevant information. The contents of this document will allow healthcare professionals to access the latest research and to promote the importance of adhering to the latest recommendations on injection technique. Promoting best practice plays a core role in GlucoRx’s day to day activities and helping to disseminate these practical guidelines could not be more in line with our company’s ethos.
Learn more here:
ITM ToolKit Guide: